🇺🇸 FDA
Pipeline program

MultiStem

B06-01

Phase 2 mab active

Quick answer

MultiStem for Trauma is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Trauma
Phase
Phase 2
Modality
mab
Status
active

Clinical trials